Search - tctmd.com

Displaying 781 - 800 of 2080

Sort: Relevancy | Date

News Daily News

Half-Dose DOAC May Be a Good Post-Watchman Option

Todd Neale

October 14, 2021

News Daily News

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Yael L. Maxwell

October 14, 2021

News Opinion Off Script

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

Juan F. Granada, MD

October 14, 2021

News Daily News

FDA Issues New Guidance on Sodium Targets for Food Industry

L.A. McKeown

October 14, 2021

News Conference News TCT 2021

No Harm From Thrombolytics in SCAD Patients With STEMI

Michael O'Riordan

October 13, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Todd Neale

October 13, 2021

Podcast Rox Heart Radio

Rox Heart Radio: Virtual vs In-Person Meetings

October 13, 2021

News Conference News TCT 2021

LAA Closure Feasible in Patients With Thrombus: Registry

Michael O'Riordan

October 13, 2021

News Daily News

HF Care Didn’t Suffer as Clinicians Turned to Telehealth in COVID-19

Caitlin E. Cox

October 13, 2021

News Opinion Conversations in Cardiology

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

October 12, 2021

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

L.A. McKeown

October 12, 2021

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 2

Todd Neale

October 11, 2021

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

L.A. McKeown

October 08, 2021

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

News Conference News VIVA 2021

Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms

L.A. McKeown

October 07, 2021

News Conference News TCT 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Michael O'Riordan

October 07, 2021

News Daily News

Higher Dose vs Added Antihypertensive? Older Patients Face Trade-offs

Yael L. Maxwell

October 07, 2021

Advertisement

Half-Dose DOAC May Be a Good Post-Watchman Option

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

FDA Issues New Guidance on Sodium Targets for Food Industry

No Harm From Thrombolytics in SCAD Patients With STEMI

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Rox Heart Radio: Virtual vs In-Person Meetings

LAA Closure Feasible in Patients With Thrombus: Registry

HF Care Didn’t Suffer as Clinicians Turned to Telehealth in COVID-19

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

COVID-19: TCTMD’s Dispatch for October Week 2

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

Failed MitraClip Is Uncommon, but Bleak When It Happens

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Higher Dose vs Added Antihypertensive? Older Patients Face Trade-offs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content